K7L
General Information
DRACP ID DRACP02639
Peptide Name K7L
Sequence LKPLLKPLLKPLLKPLLKPLLKPLLKPL
Sequence Length 28
UniProt ID Not available
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Active ACP Membrane lysis
Activity Information
Cell Line | Disease | Cancer Classified | Activity | Assay | Testing Time | Literature |
---|---|---|---|---|---|---|
RAW 264.7 | Mouse leukemia | Leukemia | IC50=1.564 µM | MTT assay | 18-24 h | 1 |
Hemolytic Activity Human erythrocytes: HC10>128 µM
Normal (non-cancerous) Cytotoxicity HEK 293T: IC50=47.4 μM
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer; Antibacterial
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Amidation
Other Modification None
Chiral L
Physicochemical Information
Formula C161H289N35O29
Absent amino acids ACDEFGHIMNQRSTVWY
Common amino acids L
Mass 366108
Pl 11.58
Basic residues 7
Acidic residues 0
Hydrophobic residues 14
Net charge 7
Boman Index 3003
Hydrophobicity 52.5
Aliphatic Index 195
Half Life
Mammalian: 20 hour
Yeast: 30 min
E.coli: >10 hour
Extinction Coefficient cystines 0
Absorbance 280nm 0
Polar residues 0
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 30742437
Title Antimicrobial Peptides with High Proteolytic Resistance for Combating Gram-Negative Bacteria
Doi 10.1021/acs.jmedchem.8b01348
Year 2019
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available